AffiGEN® TransfectTM DNA In Vivo 2000 Plus
We are thrilled to introduce our advanced AffiGEN® TransfectTM DNA In Vivo 2000 Plus, meticulously engineered by enhancing our In Vitro transfection reagent with the incorporation of several proprietary peptides. This transformative formula boasts an elevated DNA condensing capability compared to the original formulation, achieved through innovative chemistry.
Furthermore, the introduction of a shield peptide within the backbone ensures a protective barrier against In Vivo environmental interferences, ultimately resulting in remarkable In Vivo transfection efficiency.
Key Advancements:
- Enhanced DNA condensing groups through groundbreaking chemistry.
- Integration of a shield peptide to safeguard against In Vivo environmental factors.
- Proven to deliver superior renilla luciferase expression in vital organs, including the lung, spleen, liver, and kidney.
Storage Conditions:
Store at 4°C for optimal preservation.
Under proper storage conditions, this product remains stable for at least 12 months, if not longer, ensuring consistent performance and reliability.
In Vivo Transfection Reagents:
| Product | AffiGEN® TransfectTM DNA In Vivo 2000 Plus | AffiGEN® TransfectTM DNA In Vivo 3000 |
| Technology | Formulation from In Vitro transfection reagent | Novel cationic peptide |
| Length | Not specified | 28 amino-acids |
| Optimization | Refined, screened and validated |
Protein alignment and simulation software |
| Efficiency | High |
High, best renilla luciferase expression in lung, liver, spleen and kidney |
| Shield peptide | Yes | Yes |